title: [Health technology assessment and its impact on pharmaceutical pricing and reimbursement policies].
abstract: The article conceptualizes the pharmaceutical pricing and reimbursement policies related to financial coverage in the context of health systems. It introduces the pharmaceutical market as an imperfect one, in which appropriate regulation is required. Moreover, the basis that guide the pricing and reimbursement processes are defined and described in order to generate a categorization based on whether they are intended to assess the 'added value' and if the evaluation is based on cost-effectiveness criteria. This framework is used to review different types of these policies applied in the international context, discussing the role of the Health Technology Assessment in these processes. Finally, it briefly discusses the potential role of these types of policies in the Chilean context.
authors.forename: Carla
authors.initials: C
authors.lastname: Castillo-Laborde
authors.forename: Nicolás
authors.initials: N
authors.lastname: Silva-Illanes
mesh_terms: D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis / Q000191:economics; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D006801:Humans; D007349:Insurance, Health, Reimbursement / Q000191:economics*; D007356:Insurance, Pharmaceutical Services / Q000191:economics*; D013673:Technology Assessment, Biomedical / Q000191:economics*